thiazoles has been researched along with cardiovascular agents in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 8 (40.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burak, K; Machoń, Z | 1 |
| el-Sayed, OA; Farghaly, AM; Habib, NS; Khalil, MA | 1 |
| De Keyser, J; Diener, HC; Hacke, W; Hantson, L; Hennerici, M; Rådberg, J | 1 |
| Arita, J; Eto, K; Hashimoto, K; Ni, C; Sugiyama, A; Xue, YX | 1 |
| Aronowski, J; Grotta, JC; Strong, R | 1 |
| Crabbé, R; Gheuens, J; Hantson, L; Tritsmans, L; Van Rooy, P | 1 |
| Adachi, Y; Akima, M; Fukazawa, M; Kato, T; Suzuki, Y; Tamura, K | 1 |
| Lodder, J | 1 |
| Fisher, M; Schaebitz, W | 1 |
| Anthonsen, T; Berg, TC; Hoff, BH; Liu, HL | 1 |
| HOPPE, JO; LUDUENA, FP | 1 |
| Bakris, GL; Bank, AJ; Kass, DA; Neutel, JM; Oparil, S; Preston, RA | 1 |
| Cooper, ME | 1 |
| Bruno, C; Carocci, A; Catalano, A; Cavalluzzi, MM; Corbo, F; Franchini, C; Lentini, G; Tortorella, V | 1 |
| Chiang Boey, FY; Huang, CL; Kumar, S; Loo, JS; Steele, TW; Venkatraman, SS; Widjaja, E | 1 |
| Hartog, JW; Hillege, HL; Hummel, YM; Posma, JL; van Veldhuisen, DJ; van Wijk, LM; Voors, AA; Willemsen, S | 1 |
| Chen, S; Lee, F; Matsushima, N; Mendell, J; Noveck, R; Shi, M; Zahir, H; Zhang, G | 1 |
| Fang, B; Kang, Y; Liu, X; Qin, J; Xu, Z; Zang, C | 1 |
| Bridgeman, MB; Dalal, KS | 1 |
| Pu, WT; Wang, S | 1 |
3 review(s) available for thiazoles and cardiovascular agents
| Article | Year |
|---|---|
An overview of acute stroke therapy: past, present, and future.
Topics: Acute Disease; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Antibodies; Brain Ischemia; Calcium Channel Blockers; Cardiovascular Agents; Cell Adhesion Molecules; Clinical Trials as Topic; Cytidine Diphosphate Choline; Cytokines; Drug Therapy, Combination; Fibrinolytic Agents; Free Radical Scavengers; gamma-Aminobutyric Acid; Growth Substances; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; N-Methylaspartate; Neuroprotective Agents; Nootropic Agents; Piperidines; Stroke; Thiazoles; Thrombolytic Therapy | 2000 |
Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process.
Topics: Aging; Animals; Blood Pressure; Blood Vessels; Cardiovascular Agents; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Glycation End Products, Advanced; Heart Failure; Humans; Hypertension; Thiazoles | 2004 |
Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease.
Topics: Animals; Atherosclerosis; Blood Glucose; Cardiomyopathies; Cardiovascular Agents; Diabetic Angiopathies; Diabetic Nephropathies; Fibrosis; Glycation End Products, Advanced; Humans; Myocardium; Thiazoles | 2004 |
4 trial(s) available for thiazoles and cardiovascular agents
| Article | Year |
|---|---|
Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Brain Ischemia; Cardiovascular Agents; Carotid Artery Diseases; Cerebrovascular Disorders; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Intravenous; Logistic Models; Male; Middle Aged; Multivariate Analysis; Piperidines; Placebos; Safety; Thiazoles | 1996 |
The safety and tolerability of single intravenous doses of lubeluzole (Prosynap) in healthy volunteers.
Topics: Adult; Cardiovascular Agents; Dose-Response Relationship, Drug; Electrocardiography; Hemodynamics; Humans; Injections, Intravenous; Male; Piperidines; Single-Blind Method; Thiazoles | 1997 |
Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure.
Topics: Aged; Cardiovascular Agents; Chronic Disease; Diagnostic Techniques, Cardiovascular; Double-Blind Method; Exercise Tolerance; Female; Glycation End Products, Advanced; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Thiazoles | 2011 |
Drug-drug interaction studies of cardiovascular drugs involving P-glycoprotein, an efflux transporter, on the pharmacokinetics of edoxaban, an oral factor Xa inhibitor.
Topics: Adolescent; Adult; Anticoagulants; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cardiovascular Agents; Cohort Studies; Cross-Over Studies; Drug Interactions; Factor Xa Inhibitors; Female; Humans; Male; Pyridines; Thiazoles; Young Adult | 2013 |
13 other study(ies) available for thiazoles and cardiovascular agents
| Article | Year |
|---|---|
Synthesis of isothiazole derivatives with potential biological activity.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Cardiovascular Agents; Lethal Dose 50; Magnetic Resonance Spectroscopy; Male; Mice; Rats; Spectrophotometry, Infrared; Thiazoles | 1992 |
Synthesis of some thiazole-, 1,3,4-thiadiazole-, and 4H-1,2,4-triazole derivatives of pyrazolo[3,4-b]quinoline.
Topics: Animals; Anti-Bacterial Agents; Anura; Bacteria; Cardiovascular Agents; Heart Rate; In Vitro Techniques; Microbial Sensitivity Tests; Myocardial Contraction; Pyrazoles; Quinolines; Thiadiazoles; Thiazoles | 1991 |
Effects of the antihypoxic and neuroprotective drug, lubeluzole, on repolarization phase of canine heart assessed by monophasic action potential recording.
Topics: Action Potentials; Animals; Blood Pressure; Cardiac Catheterization; Cardiovascular Agents; Disease Models, Animal; Dogs; Electrocardiography; Heart; Heart Rate; Injections, Intravenous; Microelectrodes; Myocardium; Neuroprotective Agents; Piperidines; Rats; Thiazoles | 1996 |
Combined neuroprotection and reperfusion therapy for stroke. Effect of lubeluzole and diaspirin cross-linked hemoglobin in experimental focal ischemia.
Topics: Animals; Aspirin; Cardiovascular Agents; Cerebral Infarction; Cerebrovascular Disorders; Drug Therapy, Combination; Hemodilution; Hemoglobins; Male; Neuroprotective Agents; Piperidines; Rats; Rats, Inbred Strains; Reperfusion; Thiazoles | 1996 |
CP-060S, a novel cardioprotective drug, limits myocardial infarct size in anesthetized dogs.
Topics: Animals; Calcium Channel Blockers; Cardiovascular Agents; Dogs; Hemodynamics; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Necrosis; Thiazoles; Thiazolidines | 1998 |
Lubeluzole treatment of acute ischemic stroke.
Topics: Acute Disease; Brain Ischemia; Cardiovascular Agents; Cerebrovascular Disorders; Humans; Piperidines; Thiazoles | 1998 |
Synthesis of the antistroke drug lubeluzole and its enantiomer. Lipase-catalyzed resolution of chiral building block.
Topics: Cardiovascular Agents; Catalysis; Lipase; Piperidines; Propanols; Stereoisomerism; Substrate Specificity; Thiazoles | 2001 |
2-phenyl-4-thiazolidone derivatives as local anesthetics.
Topics: Anesthetics; Anesthetics, Local; Cardiovascular Agents; Thiazoles | 1951 |
Facile, alternative route to lubeluzole, its enantiomer, and the racemate.
Topics: Cardiovascular Agents; Molecular Structure; Piperidines; Stereoisomerism; Thiazoles | 2006 |
High-throughput screening of PLGA thin films utilizing hydrophobic fluorescent dyes for hydrophobic drug compounds.
Topics: Cardiovascular Agents; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Coated Materials, Biocompatible; Coumarins; Delayed-Action Preparations; Drug Carriers; Fluoresceins; Fluorescent Dyes; High-Throughput Screening Assays; Hydrophobic and Hydrophilic Interactions; Kinetics; Lactic Acid; Magnetic Resonance Spectroscopy; Microscopy; Microscopy, Electron, Scanning; Molecular Structure; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rhodamines; Solubility; Spectrometry, Fluorescence; Spectrum Analysis, Raman; Surface Properties; Technology, Pharmaceutical; Thiazoles | 2011 |
Dioscin prevents the mitochondrial apoptosis and attenuates oxidative stress in cardiac H9c2 cells.
Topics: Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Cardiovascular Agents; Cell Line; Coloring Agents; Cytochromes c; Diosgenin; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; L-Lactate Dehydrogenase; Malondialdehyde; Membrane Potential, Mitochondrial; Mitochondria; Myocardium; Myocytes, Cardiac; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Rats; Reactive Oxygen Species; RNA, Messenger; Superoxide Dismutase; Tetrazolium Salts; Thiazoles | 2014 |
Cardiovascular drugs.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzazepines; Cardiovascular Agents; Humans; Ivabradine; Pyridines; Thiazoles | 2017 |
Calcific aortic valve disease: turning therapeutic discovery up a notch.
Topics: Aortic Valve; Aortic Valve Stenosis; Calcinosis; Cardiovascular Agents; Endothelial Cells; ERRalpha Estrogen-Related Receptor; Gene Regulatory Networks; Humans; Induced Pluripotent Stem Cells; Machine Learning; Nitriles; Receptor, Notch1; Receptors, Estrogen; Thiazoles | 2021 |